Keurig Dr Pepper (NASDAQ:KDP) Stock Gets Price Target Boost from TD Cowen

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its price objective boosted by stock analysts at TD Cowen from $33.00 to $35.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “hold” rating on the stock. TD Cowen‘s price objective would indicate a potential downside of 5.16% from the stock’s previous close.

KDP has been the topic of a number of other research reports. Bank of America boosted their price objective on shares of Keurig Dr Pepper from $35.00 to $38.00 in a research report on Friday, July 10th. UBS Group boosted their price objective on shares of Keurig Dr Pepper from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Wells Fargo & Company upped their price objective on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an “overweight” rating in a research note on Wednesday. Argus reissued a “buy” rating and set a $36.00 price objective on shares of Keurig Dr Pepper in a report on Tuesday, September 15th. Finally, Morgan Stanley boosted their price target on Keurig Dr Pepper from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Wednesday. Ten analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Keurig Dr Pepper currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.65.

Read Our Latest Research Report on KDP

Keurig Dr Pepper Trading Up 6.2%

Shares of NASDAQ:KDP traded up $2.17 during trading on Wednesday, hitting $36.91. The company had a trading volume of 14,434,071 shares, compared to its average volume of 12,233,594. The stock has a market cap of $50.22 billion, a price-to-earnings ratio of 37.23, a price-to-earnings-growth ratio of 1.75 and a beta of 0.35. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.48 and a quick ratio of 0.28. The company has a fifty day simple moving average of $32.58 and a two-hundred day simple moving average of $30.07. Keurig Dr Pepper has a one year low of $24.88 and a one year high of $37.31.

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.04. Keurig Dr Pepper had a return on equity of 10.80% and a net margin of 7.10%. The firm had revenue of $7.34 billion for the quarter, compared to the consensus estimate of $7.33 billion. During the same quarter in the previous year, the company posted $0.54 EPS. The company’s revenue for the quarter was up 70.6% compared to the same quarter last year. As a group, equities analysts forecast that Keurig Dr Pepper will post 2.30 earnings per share for the current year.

Insider Buying and Selling

In other news, VP Angela A. Stephens sold 9,500 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the transaction, the vice president directly owned 55,786 shares of the company’s stock, valued at approximately $1,824,202.20. This represents a 14.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Aaron E. Alt acquired 7,862 shares of Keurig Dr Pepper stock in a transaction dated Tuesday, August 25th. The stock was purchased at an average price of $31.83 per share, with a total value of $250,247.46. Following the completion of the purchase, the director owned 7,862 shares of the company’s stock, valued at approximately $250,247.46. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.34% of the stock is owned by company insiders.

Institutional Trading of Keurig Dr Pepper

Large investors have recently made changes to their positions in the business. Vontobel Holding Ltd. lifted its position in Keurig Dr Pepper by 1.5% during the third quarter. Vontobel Holding Ltd. now owns 21,777 shares of the company’s stock valued at $661,000 after purchasing an additional 328 shares during the period. Parallel Advisors LLC grew its position in Keurig Dr Pepper by 2.6% during the 3rd quarter. Parallel Advisors LLC now owns 13,823 shares of the company’s stock worth $419,000 after purchasing an additional 353 shares during the period. WJ Financial Advisors LLC raised its stake in shares of Keurig Dr Pepper by 1.6% during the 1st quarter. WJ Financial Advisors LLC now owns 27,383 shares of the company’s stock valued at $721,000 after buying an additional 433 shares during the last quarter. CX Institutional raised its stake in shares of Keurig Dr Pepper by 2.8% during the 3rd quarter. CX Institutional now owns 17,017 shares of the company’s stock valued at $516,000 after buying an additional 469 shares during the last quarter. Finally, Vise Technologies Inc. lifted its holdings in shares of Keurig Dr Pepper by 4.0% in the 3rd quarter. Vise Technologies Inc. now owns 14,081 shares of the company’s stock valued at $427,000 after buying an additional 542 shares during the period. 93.99% of the stock is owned by hedge funds and other institutional investors.

More Keurig Dr Pepper News

Here are the key news stories impacting Keurig Dr Pepper this week:

  • Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst estimates, while net sales reached $7.34 billion, up about 70% year over year, largely reflecting the JDE Peet’s acquisition. The company reaffirmed its full-year 2026 guidance. KDP Q3 results and guidance
  • Positive Sentiment: Growth was particularly strong in beverages: energy-drink market share topped 10%, and U.S. refreshment beverage sales increased. The company’s energy portfolio and brands such as Dr Pepper Zero Sugar helped support momentum. Long-term investor takeaways
  • Positive Sentiment: Morgan Stanley raised its price target to $40 and maintained an Overweight rating; Piper Sandler also lifted its target, to $41. The higher targets signal continued analyst optimism. Morgan Stanley ratings Piper Sandler price target
  • Neutral Sentiment: KDP is preparing to separate its beverage and coffee businesses in early 2027. The potential restructuring may sharpen investor focus on each business, though execution and market conditions remain factors. 2026 sales outlook and planned separation
  • Negative Sentiment: The coffee business faces pressure as price-sensitive shoppers trade down to cheaper options. Management lowered its legacy EPS growth outlook, making beverage growth and JDE Peet’s contribution more important to the overall story. Coffee profit and consumer trading-down report

About Keurig Dr Pepper

(Get Free Report)

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.

Featured Stories

Analyst Recommendations for Keurig Dr Pepper (NASDAQ:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.